| ［1］ |
Hartzell LD, Buckmiller LM. Current management of infantile hemangiomas and their common associated conditions［J］. Otolaryngol Clin North Am, 2012, 45（3）: 545⁃556, vii. DOI: 10.1016/j.otc.2012.03.001.
|
| ［2］ |
Léauté⁃Labrèze C, Prey S, Ezzedine K. Infantile haemangioma: part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities［J］. J Eur Acad Dermatol Venereol, 2011, 25（11）: 1245⁃1253. DOI: 10.1111/j.1468⁃3083.2011.04102.x.
|
| ［3］ |
Tollefson MM, Frieden IJ. Early growth of infantile hemangiomas: what parents′ photographs tell us［J/OL］. Pediatrics, 2012, 130（2）: e314⁃320［2016⁃12⁃07］. http://pediatrics.aappublications.org/content/130/2/e314.long. DOI: 10.1542/peds.2011⁃3683.
|
| ［4］ |
Léauté⁃Labrèze C, de la Roque ED, Hubiche T, et al. Propranolol for severe hemangiomas of infancy［J］. N Engl J Med, 2008, 358（24）: 2649⁃2651. DOI: 10.1056/NEJMc0708819.
|
| ［5］ |
Gunturi N, Ramgopal S, Balagopal S, et al. Propranolol therapy for infantile hemangioma［J］. Indian Pediatr, 2013, 50（3）: 307⁃313.
|
| ［6］ |
Zimmermann AP, Wiegand S, Werner JA, et al. Propranolol therapy for infantile haemangiomas: review of the literature［J］. Int J Pediatr Otorhinolaryngol, 2010, 74（4）: 338⁃342. DOI: 10.1016/j.ijporl.2010.01.001.
|
| ［7］ |
Painter SL, Hildebrand GD. Review of topical beta blockers as treatment for infantile hemangiomas［J］. Surv Ophthalmol, 2016, 61（1）: 51⁃58. DOI: 10.1016/j.survophthal.2015.08.006.
|
| ［8］ |
Hao J, Yang MB, Liu H, et al. Distribution of propranolol in periocular tissues: a comparison of topical and systemic administration［J］. J Ocul Pharmacol Ther, 2011, 27（5）: 453⁃459. DOI: 10.1089/jop.2011.0055.
|
| ［9］ |
Chantasart D, Hao J, Li SK. Evaluation of skin permeation of β⁃blockers for topical drug delivery［J］. Pharm Res, 2013, 30（3）: 866⁃877. DOI: 10.1007/s11095⁃012⁃0928⁃9.
|
| ［10］ |
Torres⁃Pradilla M, Baselga E. Failure of intralesional propranolol in infantile hemangiomas［J］. Pediatr Dermatol, 2014, 31（2）: 156⁃158. DOI: 10.1111/pde.12175.
|
| ［11］ |
Chen ZG, Zheng JW, Yuan ML, et al. A novel topical nano⁃propranolol for treatment of infantile hemangiomas［J］. Nanomedicine, 2015, 11（5）: 1109⁃1115. DOI: 10.1016/j.nano. 2015.02.015.
|
| ［12］ |
祁敏, 陈翔, 谢红付, 等. 外用普萘洛尔凝胶在婴幼儿浅表血管瘤中的应用［J］. 中国当代儿科杂志, 2014, 16（8）: 860⁃862. DOI: 10.7499/j.issn.1008⁃8830.2014.08.018.
|
|
Qi M, Chen X, Xie HF, et al. Topical propranolol gel for super⁃ficial infantile hemangiomas［J］. Chin J Contemp Pediatr, 2014, 16 （8）: 860⁃862. DOI: 10.7499/j.issn.1008⁃8830.2014.08.018.
|
| ［13］ |
Xu DP, Cao RY, Tong S, et al. Topical timolol maleate for superficial infantile hemangiomas: an observational study［J］. J Oral Maxillofac Surg, 2015, 73（6）: 1089⁃1094. DOI: 10.1016/j.joms.2014.12.026.
|
| ［14］ |
Tawfik AA, Alsharnoubi J. Topical timolol solution versus laser in treatment of infantile hemangioma: a comparative study［J］. Pediatr Dermatol, 2015, 32（3）: 369⁃376. DOI: 10.1111/pde.12542.
|
| ［15］ |
Ciudad BC, Campos DM, Moreno GB, et al. Episcleral infantile hemangioma successfully treated with topical timolol［J］. Dermatol Ther, 2015, 28（1）: 22⁃24. DOI: 10.1111/dth.12173.
|
| ［16］ |
Beal BT, Chu MB, Siegfried EC. Ulcerated infantile hemangioma: novel treatment with topical brimonidine⁃timolol［J］. Pediatr Dermatol, 2014, 31（6）: 754⁃756. DOI: 10.1111/pde.12420.
|
| ［17］ |
Park KH, Jang YH, Chung HY, et al. Topical timolol maleate 0.5 for infantile hemangioma; it′s effectiveness and/or adjunctive pulsed dye laser ⁃ single center experience of 102 cases in Korea［J］. J Dermatolog Treat, 2015, 26（4）: 389⁃391. DOI: 10.3109/09546634.2014.990412.
|
| ［18］ |
Ma G, Wu P, Lin X, et al. Fractional carbon dioxide laser⁃assisted drug delivery of topical timolol solution for the treatment of deep infantile hemangioma: a pilot study［J］. Pediatr Dermatol, 2014, 31（3）: 286⁃291. DOI: 10.1111/pde.12299.
|
| ［19］ |
Hu L, Huang HZ, Li X, et al. Open⁃label nonrandomized left⁃right comparison of imiquimod 5 ointment and timolol maleate 0.5 eye drops in the treatment of proliferating superficial infantile hemangioma［J］. Dermatology, 2015, 230（2）: 150⁃155. DOI: 10.1159/000369164.
|
| ［20］ |
Qiu Y, Ma G, Yang J, et al. Imiquimod 5 cream versus timolol 0.5 ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study［J］. Clin Exp Dermatol, 2013, 38（8）: 845⁃850. DOI: 10.1111/ced.12150.
|
| ［21］ |
Qiu Y, Ma G, Lin X, et al. Treating protruding infantile hemangiomas with topical imiquimod 5 cream caused severe local reactions and disfiguring scars［J］. Pediatr Dermatol, 2013, 30（3）: 342⁃347. DOI: 10.1111/pde.12002.
|
| ［22］ |
Couto JA, Greene AK. Management of problematic infantile hemangioma using intralesional triamcinolone: efficacy and safety in 100 infants［J］. J Plast Reconstr Aesthet Surg, 2014, 67（11）: 1469⁃1474. DOI: 10.1016/j.bjps.2014.07.009.
|
| ［23］ |
Zhang L, Zheng JW, Yuan WE. Treatment of alarming head and neck infantile hemangiomas with interferon⁃α2a: a clinical study in eleven consecutive patients［J］. Drug Des Devel Ther, 2015, 9: 723⁃727. DOI: 10.2147/DDDT.S67682.
|
